Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma

BACKGROUND: Inhaled corticosteroids are the recommended first-line treatment for asthma but adherence to therapy is suboptimal. The objectives of this study were to compare the efficacy and safety of once-daily (OD) evening and twice-daily (BD) regimens of the novel inhaled corticosteroid fluticason...

Descripción completa

Detalles Bibliográficos
Autores principales: Woodcock, Ashley, Bleecker, Eugene R, Busse, William W, Lötvall, Jan, Snowise, Neil G, Frith, Lucy, Jacques, Loretta, Haumann, Brett, Bateman, Eric D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282675/
https://www.ncbi.nlm.nih.gov/pubmed/22188590
http://dx.doi.org/10.1186/1465-9921-12-160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282675/
https://www.ncbi.nlm.nih.gov/pubmed/22188590
http://dx.doi.org/10.1186/1465-9921-12-160

Ejemplares similares